Close

OncoMed Pharma (OMED) Plans Presentation of Demcizumab, Tarextumab Data at AACR 2015

April 21, 2015 8:31 AM EDT Send to a Friend
OncoMed Pharma (NASDAQ: OMED) will present new data related to its clinical and preclinical anti-cancer stem cell and immuno-oncology candidates ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login